Background
Cancer is one of the leading causes of mortality and represents a tremendous burden on patients and societies. Colorectal cancers are associated with one of the highest morbidity and mortality rates in both men and women (Globocan 2008, IARC 2010). Although the etiology of cancer varies greatly between different types of neoplasms, a hallmark finding is a defect in cell cycle regulation [
1,
2]. Such cell cycle disruption is associated with genomic instability, due to mutations and chromosomal aberrations that disrupt critical housekeeping functions, including DNA repair and cell cycle checkpoints. Because these homeostatic mechanisms are essential for both normal and cancerous cells, treatments targeted at selectively destroying cancer cells become challenging.
The G2-M transition marks the entry of cells into the division phase of the cell cycle. Interestingly, metal chelation using the acyclic amino metal chelator
N,
N,
N’,
N’-tetrakis-[2-pyridylmethyl]-ethylenediamine (TPEN) prevents frog oocytes from entering meiosis [
3]. TPEN, an uncharged polydentate ligand with nitrogens as donor atoms, has remarkably high affinity for a broad spectrum of metal ions, including copper, iron and zinc [
4]. TPEN-induced meiotic arrest is due to the lack of activation of Cdc25C, a dual specificity phosphatase in oocytes that represents the rate limiting step in activating the master regulator of the G2-M transition cyclin-dependent kinase 1 (Cdk1) [
5]. This is because Cdc25C is a Zn
2+-binding protein and removal of Zn
2+ inhibits its ability to interact with and dephosphorylate Cdk1 [
3]. TPEN treatment also results in meiosis arrest in mouse oocytes [
6].
TPEN-dependent metal chelation has noticeably distinct effects during the mitotic cell cycle as compared to meiosis. TPEN induces apoptosis in different cell types, including lymphocytes and splenocytes [
7,
8], epithelial cells [
9], hepatocytes [
10], breast cancer [
11], HT-29 colorectal cancer [
12], ovarian cancer [
13], pancreatic cancer [
14], and prostate cancer [
15]. However the mechanisms of actions proposed for the TPEN-dependent cell killing are quite varied: TPEN was proposed to decrease the levels of the apoptosis inhibitor XIAP due to Zn
2+ chelation [
15]. Zn
2+ depletion has also been implicated in mitochondrial injury, activation of caspases (primarily caspase 3) and apoptosis [
8,
9,
14]. Furthermore, TPEN treatment results in depletion of glutathione causing increased redox stress [
10]. Collectively these findings argue that TPEN induces cell killing through varied mechanisms, which may be expected given the diverse roles that metals chelated by TPEN play in physiological processes. Indeed TPEN has been used as a selective Zn
2+ chelator despite the fact that it has a significantly higher affinity for Cu
2+ (Stability constant for Zn 15.5 and for Cu 20.5) [
16]. There is evidence at least in the hippocampus that TPEN
in vivo chelates Zn
2+ with better efficiency as compared to Cu
2+[
17].
Metal homeostasis is important for biological function and needs to be tightly regulated since either metal deficiencies or metal excesses tend to be toxic. Metals have played important roles in cancer treatment since ancient times with the use of arsenic trioxide to treat different cancers including leukemia in the 18
th and 19
th century [
18]. More recently platinum based compounds such as cysplatin and carboplatin have become the chemotherapeutic agents of choice for many cancers [
19]. Interestingly cancer cells are addicted to high iron levels and accumulate the metal through transferrin-dependent uptake [
20,
21]. Furthermore cancer cells concentrate high levels of copper, which is presumed to be important for both angiogenesis and metastasis [
22]. Therefore, transition metals are likely to play important roles in the development and growth and neoplasms.
Here we show that TPEN-mediated metal chelation results in selective killing of HCT116 colon cancer cells without affecting normal cells. TPEN cytotoxicity is due to the generation of ROS as it is reversed by antioxidants. Interestingly, HCT116 colon cancer cells accumulate 7-fold higher levels of copper compared to normal cells. The TPEN-copper complex undergoes redox cycling reactions. These results suggest that TPEN chelates accumulated copper in HCT116 cells making it available for redox cycling leading to cell toxicity and death. We further show that TPEN effectively inhibits colon cancer tumor growth in human colon cancer xenografts in mice. Therefore metal chelation provides a promising selective approach to target colon cancer.
Methods
Cell culture
Human colorectal cancer cells, SW480, HT-29 and LOVO were kindly provided by the American Type Culture Collection (ATCC). Cells were cultured in RPMI 1640 (Sigma-Aldrich, UK) with 20mM HEPES and L-Glutamine at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Media was supplemented with 1% Penicillin-Streptomycin (100 U/ml) and 10% heat-inactivated FBS (Sigma-Aldrich, Germany). Unless otherwise mentioned, cells were seeded at 1.2 ×105 cells/ml and treated with TPEN (Sigma-Aldrich) at 50% confluence. TPEN was prepared in DMSO and the final DMSO concentration used on cells <0.3%.
Cell viability assays & antibodies
Human HCT116 p53
+/+ colon cancer cells were cultured as previously described [
23]. Cell viability was measured using the MTT-based Cell Titer 96 non-radioactive cell proliferation kit (Promega Corp, Madison, Wisconsin, USA). Cell cycle analyses were performed on propidium iodide stained cells using flow cytometry (Becton Dickinson, Research Triangle, NC). The TUNEL assay used the
In Situ Cell Death Detection Kit according to the manufacture instructions (Roche Diagnostics Corporation, Mannheim, Germany). For Annexin V staining cells were incubated in Annexin-V-Fluos labeling solution [20 μl Annexin reagent and 20 μl PI (50 μg/ml) in 1000 μl incubation buffer pH 7.4 (10 mM Hepes/NaOH, 140 mM NaCl, 5 mM CaCl
2), then analyzed by flow cytometry. Caspase 3, 8 and 9 activities were assessed using Colorimetric Assay kits according to manufacturer insutructions (R & D Systems-BF4100). Primary antibody used for Western blots: XIAP #2042S; Caspase 3 #9665S; Caspase 9 #9502S; Bax #2772; PARP #9542S, from Cell Signaling. Cytochrome C sc-13560 from Santa-Cruz and GAPDH #5476 from Abnova.
DCFH assay
Cells were treated with TPEN for 10, 20, 30 and 45 min. In experiments which involved addition of the antioxidant N-acetyl-L-cysteine (NAC), cells were treated with 5 mM NAC for 2 h before TPEN after which 10 μM of the CM-H2DCFDA dye was added for 20 min. Cells were washed, harvested by centrifugation and the pellet washed and re-suspended in 500 μl PBS followed by flow cytometery.
Mitochondrial membrane potential
Cells were washed, pelleted and incubated in 500 μl of rhodamine buffer [5 μm rhodamine 123, 130 mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 1 mM CaCl2, 1 mM CaCl2, 1 mM MgCl2, and 25 mM Hepes (pH7.4)] for 30 min at 37°C, then analyzed by flow cytometry.
Atomic absorption
106 HCT116 and NCM460 cells were collected in 8 ml HNO3 65% + 2 ml H2O2 30% and digested in a closed vessel microwave (Milestone ETHOS PLUS with HPR-1000/10S high pressure rotor). Cell lysates were measured for ion concentration against standard solutions prepared for Copper, Zinc and Iron in deionized water in an atomic absorption spectrophotometer (Furnace).
UV/VIS and EPR spectroscopy
EPR spin-trapping experiments were carried out with a JEOL-RE1X spectrometer (Kyoto, Japan). Spectrometer settings were as follows: field center, 335.094 mT; microwave power, 10 mW; sweep time, 2.0 min; time constant, 0.3 s; and modulation width, 0.2 mT). UV/VIS spectra were recorded with Helios Alpha spectrophotometer (Thermo Fisher Scientific, Inc.; Pittsburgh, PA). All measurements were performed at room temperature.
Mouse xenografts
NOD/SCID female mice, (6–8 weeks, ~20 g) (Charles River Laboratories, France) were divided into two groups of 8 mice each and maintained in Maxi-miser hepafiltered facility. 2-3×106 HCT-116 tumor cells in 100 μl of 0.9% NaCl were inoculated subcutaneously in the flank. An average age (6–8 weeks) and body weight of mice (18-22 g) were used for the experiments. Prior to manipulations, mice were anaesthetized with isoflurane (Forane®, Abbott) by inhalation. On day 7 post inoculation mice received i.p. injections of either saline (control) or 20 mg/kg TPEN every other day for 28 days. Tumor measurements were performed 3 times per week using a sterile Vernier caliper. Tumor volume was calculated by the formula: Volume = π/6 (length × width × height). A 5-10% loss of body weight was detected in mice receiving TPEN treatment in comparison to the control but they otherwise looked healthy and tolerated the drug treatment well. The use of laboratory animals was in accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC). The IACUC committee at the American University of Beirut where the animal studies were conducted reviewed and approved the studies described.
Immunohistochemical analysis of xenografts
Tissue sections (4 μm) were stained with and anti-Ki-67 antibody (Santa-Cruz, US), for 60 min followed by secondary and tertiary antibodies and incubated with the chromogen (Zymed, US) before counterstaining with Hematoxylin. To assess the extent of total cell death, tissue sections were stained by using the terminal deoxyribonucleotidyl transferase-mediated dUTP-nick-end labeling (TUNEL) assay, according to manufacturer’s instructions (in situ cell death detection kit, fluorescein; Roche) and counterstained with PI. Slides were analyzed under LSCM fluorescent confocal microscope (LSM 410, Zeiss, Germany).
Statistical analyses
Data are expressed as the mean ± standard deviation, and statistical significance between different groups was determined using a two-tailed Student’s t-test. Statistical significance was defined as a *p < 0.05 and **p < 0.01.
Discussion
Metals such as iron, copper and zinc are essential elements in mammalian cells and are used as cofactors or as structural components of many enzymes. However, an excess of these metals causes toxicity. Therefore a balance between metal accumulation, their sequestration within cellular compartments, and their association with cellular proteins is essential for the maintenance of cell viability [
35,
36]. Transient intracellular elevations of free iron or copper is toxic because of their redox reactivity and participation in ROS metabolism. In particular, low molecular mass complexes of Fe
(II) and Cu
(II) can react with hydrogen peroxide to generate hydroxyl radical, which is believed to be the most toxic form of ROS encountered in cells.
Here we show that this detrimental effect of transition metals can be used effectively to selectively eliminate cancer cells. TPEN is efficient at selectively eliminating colon cancer cells both in the dish and
in vivo in mice. The mechanism of action of TPEN depends first on its high affinity for metals and as such its ability to strip intracellular metals from cellular proteins. Second colon cancer cells accumulate copper to significantly higher levels than normal colon cells. Finally, the TPEN-copper complex engages in redox cycling and the generation of ROS (hydroxyl radicals). Hence, TPEN selectively eliminates colon cancer cells using an elegant mechanism that relies on the biology of the cancer through its tendency to accumulate copper, a feature that is common to many other cancers including breast, ovarian, stomach, colorectal and leukemia [
22]. As such the TPEN-dependent selective killing observed in this study is likely to be applicable to other cancers that accumulate redox active metals.
However, TPEN anti-tumor activity is likely to involve additional mechanisms since antioxidants treatment was not fully effective at reversing TPEN toxicity (Figure
3). TPEN toxicity is likely to be partly due to the removal of zinc from essential Zn-dependent proteins as previously reported by others [
7‐
15].
Another metal chelator that shows selective antitumor activity is di-2-pyridylk-etone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT). Dp44mT is thought to act in a similar fashion to TPEN through iron chelation and redox cycling to generate ROS [
37,
38]. Dp44mT toxicity is also believed to involve activation of the lysosomal apoptotic pathway through its copper binding capacity [
20].
Interestingly, cancer cells are known to have an altered redox status with an up-regulation of oxidative stress and an augmentation of antioxidant capacity (reviewed in [
39]). It is also thought that a moderate increase in ROS enhances cell survival and proliferation [
40]. Therefore the observed increase in ROS in cancer cells may promote tumorigenesis [
39]. However, the increased basal ROS in cancer cells brings them closer to the toxicity threshold where the intrinsic antioxidant capacity, although enhanced, is not sufficient to contain toxic ROS levels [
39]. Therefore increased oxidative stress in cancer cells represents an effective mechanism to eliminate cancer cells [
39].
In summary, selective killing of colon cancer cells can be achieved using TPEN, where the transition metal-chelator complex engages in redox cycling and the generation of hydroxyl radicals. This is an attractive potential anti-tumor therapeutic approach because its mechanism of action depends on the biology of cancer cells, including the significant accumulation of copper and their endogenous enhanced oxidative stress. Therefore, selectivity toward elimination of cancer cells without affecting normal cells is inherent in this approach because of different homeostatic mechanisms in cancer versus normal cells. In that context it would be attractive to systematically explore the redox cycling potential of metal chelators already in the clinic for the treatment of other diseases.
Conclusions
TPEN, a membrane permeant metal chelator, selectively kills colon cancer cells without affecting the viability of normal cells. TPEN is effective at preventing tumor growth in a xenograft model. The mechanism of action of TPEN involves chelation of intracellular copper, making it available for redox cycling thus leading to the generation of ROS and cell death. Because colon cancer cells accumulate copper to 7 folds higher levels than control cells, this endows TPEN with its selective killing ability. Therefore, the mechanism of action of TPEN offers an attractive anti-tumor therapeutic approach potentially for a multitude of cancers that accumulate copper.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MF, RAM, and DAS designed and performed experiments and analyzed data; OR, AZ, and HH performed experiments; VEK, HGM and KM designed experiments and analyzed data; MF, HGM and KM wrote the paper. All authors read and approved the final manuscript.